Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer

by | Mar 24, 2026 | Clinical Trials | 0 comments

​ Conditions: Hypofractionated Dose; Prostate Cancer Patients

Interventions: Radiation: Hypofractionated Intensity-Modulated Radiation Therapy; Radiation: Conventional Intensity-Modulated Radiation Therapy

Sponsors: Tanta University

Completed Conditions: Hypofractionated Dose; Prostate Cancer Patients
Interventions: Radiation: Hypofractionated Intensity-Modulated Radiation Therapy; Radiation: Conventional Intensity-Modulated Radiation Therapy
Sponsors: Tanta University
Completed 

Submit a Comment

Your email address will not be published. Required fields are marked *